An increased expression of Bcl-xL (B-cell lymphoma extra-large) and MMP9 (matrix metallopeptidase 9) in HCC has been found to correlate positively with the activation of the Nrf2 signaling pathway, according to research. Here, BCL2L1 is linked to hepatocellular carcinoma.